Literature DB >> 1033175

125I-Radioimmunoassay of amikacin and comparison with a microbioassay.

P Stevens, L S Young, W L Hewitt.   

Abstract

A radioimmunoassay (RIA) has been developed using 125I-amikacin. Amikacin was iodinated by a modified BOLTON and HUNTER method. Dextran-charcoal was used to separate bound from free drug. The standard curve was linear on a logit-log plot in the range of 0.5 ng to 4 ng amikacin per tube. There was no cross-reactivity of amikacin antisera to the amino-glycosides gentamicin, tobramycin, netilmicin, and sisomicin but a 70% cross-reaction was observed with kanamycin, the compound from which amikacin is synthetically derived. Correlation of the RIA with a microbioassay for the determination of serum amikacin levels in 18 patient samples was excellent (r = 0.94). This new RIA technique is more sensitive, rapid, versatile, and less costly than the RIA using 3H-amikacin, and is far more sensitive and faster than microbioassay.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1033175     DOI: 10.7164/antibiotics.29.829

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  5 in total

1.  125I radioimmunoassay of netilmicin.

Authors:  P Stevens; L S Young; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

2.  Spectrophotometric assay for amikacin using purified kanamycin acetyltransferase.

Authors:  E Scarbrough; J W Williams; D B Northrop
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

3.  Inactivation of amikacin and gentamicin by carbenicillin in patients with end-stage renal failure.

Authors:  D C Blair; D O Duggan; E T Schroeder
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

4.  Substrate-labeled fluorescent immunoassay for amikacin in human serum.

Authors:  S G Thompson; J F Burd
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

5.  Serial trough and peak amikacin levels in plasma as predictors of nephrotoxicity.

Authors:  A M Contreras; G Gamba; J Cortés; Y Santiago; F Nares; G Jimenez-Sanchez; J Bobadilla; G López; A Valadez; A Espinosa
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.